Publications

A complete listing of publications, presentations and reports is available here.

Titles listed below link to PubMed listing when available.

 1) Muzaale AD, Althoff KN, Sperati CJ, Abraham AG, Kucirka LM, Massie AB, Kitahata MM, Horberg MA, Justice AC, Fischer MJ, Silverberg MJ, Butt AA, Boswell SL, Rachlis AR, Mayor AM, Gill MJ, Eron JJ, Napravnik S, Drozd DR, Martin JN, Bosch RJ, Durand C, Locke JE, Moore RD, Lucas GM, Segev DL. Risk of End Stage Renal Disease in HIV-positive Potential Live Kidney Donors. Accepted for publication in Am J Transplant
 2) Wong C, Gange SJ, Buchacz K, Moore RD, Justice AC, Horberg MA, Gill MJ, Koethe JR, Rebeiro PF, Silverberg MJ, Palella FJ, Patel P, Kitahata MM, Crane HM, Abraham AG, Samji H, Napravnik S, Ahmed T, Thorne JE, Bosch RJ, Mayor AM, Althoff KN. First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected adults, 2000-2013. Clin Infect Dis. 2016 Dec 10. pii: ciw804. [Epub ahead of print]
 3) Shiels MS, Althoff KN, Pfeiffer RM, Achenbach CJ, Abraham AG, Castilho J, Cescon A, D'Souza G, Dubrow R, Eron JJ, Gebo K, John Gill M, Goedert JJ, Grover S, Hessol NA, Justice A, Kitahata M, Mayor A, Moore RD, Napravnik S, Novak RM, Thorne JE, Silverberg MJ, Engels EA. HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers. Clin Infect Dis. 2016 Dec 10. pii: ciw764. [Epub ahead of print]
 4) Althoff KN. The Shifting Paradigm of Care for Adults Living With HIV: Smoking Cessation for Longer Life. J Infect Dis. 2016 Dec 1;214(11):1618-1620. PMCID: PMC5144730
 5) Buchacz K, Lau B, Jing Y, Bosch R, Abraham AG, Gill MJ, Silverberg MJ, Goedert JJ, Sterling TR, Althoff KN, Martin JN, Burkholder G, Gandhi N, Samji H, Patel P, Rachlis A, Thorne JE, Napravnik S, Henry K, Mayor A, Gebo K, Gange SJ, Moore RD, Brooks JT. Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010. J Infect Dis. 2016 Sep 15;214(6):862-72. PMCID: PMC4996145
 6) 6) Klein MB, Althoff KN, Jing Y, Lau B, Kitahata M, Lo Re V 3rd, Kirk GD, Hull M, Kim HN, Sebastiani G, Moodie EE, Silverberg MJ, Sterling TR, Thorne JE, Cescon A, Napravnik S, Eron J, Gill MJ, Justice A, Peters MG, Goedert JJ, Mayor A, Thio CL, Cachay ER, Moore R; North American AIDS Cohort Collaboration on Research and Design of IeDEA. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras. . Clin Infect Dis. 2016 Nov 1;63(9):1160-1167. PMCID: PMC5064164
 7) Rachlis B, Karwa R, Chema C, Pastakia S, Olsson S, Wools-Kaloustian K, Jakait B, Maina M, Yotebieng M, Kumarasamy N, Freeman A, de Rekeneire N, Duda SN, Davies MA, Braitstein P. Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale. Drug Saf. 2016 Jun 9. [Epub ahead of print]
 8) Koethe JR, Jenkins CA, Lau B, Shepherd BE, Wester W, Rebeiro PF, Silverberg MJ, Thorne JE, Gill J, Mayor AM, Willig A, Bosch R, Horberg MA, Justice AC, Sterling TR, Moore RD. Higher Time-updated Body Mass Index: Association with Improved CD4+ Cell Recovery on HIV Treatment. J Acquir Immune Defic Syndr. 2016 Apr 21. [Epub ahead of print]
 9) Pettit AC, Mendes A, Jenkins C, Napravnik S, Freeman A, Shepherd BE, Dowdy D, Gill J, Rachlis A, Moore R, Sterling TR; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) investigators of International epidemiologic Databases to Evaluate AIDS (IeDEA). Timing of Antiretroviral Treatment, Immunovirologic Status and TB Risk: Implications for Test and Treat. J Acquir Immune Defic Syndr. 2016 Apr 5. [Epub ahead of print]
 10) Althoff KN, Rebeiro PF, Hanna DB, Padgett D, Horberg MA, Grinsztejn B, Abraham AG, Hogg R, Gill MJ, Wolff MJ, Mayor A, Rachlis A, Williams C, Sterling TR, Kitahata MM, Buchacz K, Thorne JE, Cesar C, Cordero FM, Rourke SB, Sierra-Madero J, Pape JW, Cahn P, McGowan C; North American Aids Cohort Collaboration on Research and Design (NA-ACCORD) and Caribbean, Central and South America Network for Hiv Epidemiology (CCASAnet). A Picture is Worth a Thousand Words: Maps of HIV Indicators to Inform Research, Programs, and Policy from NA-ACCORD and CCASAnet Clinical Cohorts. J Int AIDS Soc. 2016 Apr 4;19(1):20707. PMCID: PMC4821890
 11) Cesar C, Koethe JR, Giganti MJ, Rebeiro P, Althoff KN, Napravnik S, Mayor A, Grinsztejn B, Wolff M, Padgett D, Sierra-Madero J, Gotuzzo E, Sterling TR, Willig J, Levison J, Kitahata M, Rodriguez-Barradas MC, Moore RD, McGowan C, Shepherd BE, Cahn P; Caribbean, Central and South America Network for HIV epidemiology (CCASAnet) and North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Health Outcomes Among HIV-Positive Latinos Initiating Antiretroviral Therapy in North America versus Central and South America. J Int AIDS Soc. 2016 Mar 18;19(1):20684. PMCID: PMC4800379
 12) Rebeiro PF, Gange SJ, Horberg MA, Abraham AG, Napravnik S, Samji H, Yehia BR, Althoff KN, Moore RD, Kitahata MM, Sterling TR, Curriero FC; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Geographic Variations in Retention in Care among HIV-Infected Adults in the United States. PLoS One. 2016 Jan 11;11(1):e0146119. PMC4708981
 13) Rebeiro PF, Althoff KN, Lau B, Gill MJ, Abraham AG, Horberg MA, Kitahata MM, Yehia BR, Samji H, Brooks JT, Buchacz K, Napravnik S, Silverberg MJ, Rachlis A, Gebo KA, Sterling TR, Moore RD, and Gange SJ for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Laboratory measures are imperfect proxies of primary care encounters: implications for quantifying clinical retention among HIV-infected adults in North America. Am J Epidemiol. 2015 Dec 1;182(11):952-60. PMC4655744
 14) Koethe JR, Jenkins CA, Lau B, Shepherd BE, Justice AC, Tate JP, Buchacz K, Napravnik S, Mayor AM, Horberg MA, Blashill AJ, Willig A, Wester CW, Silverberg MJ, Gill J, Thorne JE, Klein M, Eron JJ, Kitahata MM, Sterling TR, Moore RD; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada. AIDS Res Hum Retroviruses. 2016 Jan;32(1):50-8. PMC4692122
 15) Silverberg MJ, Lau B, Achenbach CJ, Jing Y, Althoff KN, D’Souza G, Engels EA, Hessol N, Brooks JT, Burchell AN, Gill MJ, Goedert JJ, Hogg R, Horberg MA, Kirk GD, Kitahata MM, Korthuis PT, Mathews WC, Mayor A, Modur SP, Napravnik S, Novak RM, Patel P, Rachlis AR, Sterling TR, Willig JH, Justice AC, Moore RD and Dubrow R for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Cumulative Incidence of Cancer among HIV-infected Individuals in North America. Ann Intern Med. 2015 Oct 6;163(7):507-18. PMC4711936
 16) Poteat T, Hanna D, Althoff KN. Feasibility and acceptability of developing a multi-site clinical cohort of transgender people with HIV infection. AIDS Res Hum Retroviruses. 2015 Sep;31(9):870-2. [PubMed - in process]
 17) Kitahata MM, Drozd DR, Crane HM, Van Rompaey SE, Althoff KN, Gange SJ, Klein MB, Lucas GM, Abraham AG, Lo Re V, McReynolds J, Lober WB, Mendes A, Modur SP, Jing Y, Morton EJ, Griffith MA, Freeman AM and Moore RD Ascertainment and verification of end-stage renal and liver disease in the North American AIDS Cohort Collaboration on Research and Design AIDS Res Treat. 2015; 2015:923194. Epub 2015 Feb 19. PMC4350581
 18) Koethe JR, Jenkins CA, Lau B, Shepherd BE, Silverberg MJ, Brown TT, Blashill AJ, Anema A, Willig A, Stinnette S, Napravnik S, Gill MJ, Crane HM, Sterling TR. Body Mass Index and Early CD4+ T-cell Recovery among Adults Initiating Antiretroviral Therapy in North America, 1998-201   HIV Med. 2015 Oct;16(9):572-7. PMC4558259
 19) Geng EH, Neilands TB, Thièbaut R, Bwana MB, Nash D, Moore RD, Wood R, Zannou DM, Althoff KN, Lim PL, Nachega JB, Easterbrook PJ, Kambugu A, Little F, Nakigozi G, Nakanjako D, Kiggundu V, Ki Li PC, Bangsberg DR, Fox MP, Prozesky H, Hunt PW, Davies MA, Reynolds SJ, Egger M, Yiannoutsos CT, Vittinghoff EV, Deeks SG, Martin JN. CD4+ T cell Recovery during Suppression of HIV Replication: a Global Comparison of the Immunologic Efficacy of Antiretroviral Therapy.   Int J Epidemiol. 2015 Feb;44(1):251-63.  PMC4339766
 20) Yehia BR, Rebeiro PF, Althoff KN, Agwu AL, Horberg MA, Samji H, Napravnik S, Mayer KH, Tedaldi E, Silverberg MJ, Thorne JE, Burchell AN, Rourke SB, Rachlis A, Mayor A, Gill MJ, Zinski A, Ohl M, Anastos K, Abraham AG, Kitahata MM, Moore RD and Gebo KA; for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). The Impact of Age on Retention in Care and Viral Suppression J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):413-9.  PMC4334738
 21) Abraham AG, Althoff KN, Jing Y, Estrella MM, Kitahata MM, Wester CW, Bosch RJ, Crane HM, Eron JJ, Gill MJ, Horberg MA, Justice AC, Klein MB, Mayor AM, Moore RD, Palella FJ, Parikh CR, Silverberg MJ, Golub ET, Jacobson LP, Napravnik S, Lucas GM; for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA). End Stage Renal Disease Among HIV-Infected Adults in North America Clin Infect Dis. 2015 Mar 15;60(6):941-9. PMC4357817
 22) Duda SN, Farr AM, Lindegren ML, Blevins M, Wester CW, Wools-Kaloustian K, Ekouevi DK, Egger M, Hemingway-Foday J, Cooper DA, Moore RD, McGowan CC, Nash D; International Epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration. Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration.  J Int AIDS Soc. 2014 Dec 15;17:19045. PMC4268491
 23) Rebeiro PF, Horberg MA, Gange SJ, Gebo KA, Yehia BR, Brooks JT, Buchacz K, Silverberg MJ, Gill MJ, Moore RD, Althoff KN; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Strong agreement of nationally recommended retention measures from the institute of medicine and department of health and human services.  PLoS One. 2014 Nov 6;9(11):e111772. PMC4222946
 24) Beachler DC, Abraham AG, Silverberg MJ, Jing Y, Fakhry C, Gill MJ, Dubrow R, Kitahata MM, Klein MB, Burchell AN, Korthuis PT, Moore RD, D'Souza G; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals.  Oral Oncol. 2014 Dec;50(12):1169-76. PMC4253676
 25) Wong C, Althoff KN, Gange SJ. Identifying the appropriate comparison group for HIV-infected individuals.  Curr Opin HIV AIDS. 2014 Jul;9(4):379-85. PMC4105851
 26) Althoff KN, Rebeiro PF, Brooks JT, Buchacz K, Gebo KA, Martin JN, Hogg RS, Thorne JE, Klein MB, Gill MJ, Sterling TR, Yehia BR, Silverberg MJ, Crane HM, Justice AC, Gange SJ, Moore RD, Kitahata MM, Horberg MA for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Disparities in the quality of HIV care when using US Department of Health and Human Services Indicators.  Clin Infect Dis. 2014 Apr;58(8):1185-9. PMC3967825
 27) Avila D, Althoff KN, Mugglin C, Wools-Kaloustian K, Koller M, Dabis F, Nash D, Gsponer T, Sungkanuparph S, McGowan C, May M, Cooper D, Chimbetete C, Wolff M, Collier A, McManus H, Davies MA, Costagliola D, Crabtree-Ramirez B, Chaiwarith R, Cescon A, Cornell M, Diero L, Phanuphak P, Sawadogo A, Ehmer J, Eholie SP, Li PC, Fox MP, Gandhi NR, González E, Lee CK, Hoffmann CJ, Kambugu A, Keiser O, Ditangco R, Prozesky H, Lampe F, Kumarasamy N, Kitahata MM, Lugina E, Lyamuya R, Vonthanak S, Fink V, d'Arminio Monforte A, Luz PM, Chen YM, Minga A, Casabona J, Mwango A, Choi JY, Newell ML, Bukusi EA, Ngonyani K, Merati TP, Otieno J, Bosco MB, Phiri S, Ng OT, Anastos K, Rockstroh J, Santos I, Oka S, Somi G, Stephan C, Teira R, Wabwire D, Wandeler G, Boulle A, Reiss P, Wood R, Chi BH, Williams C, Sterne JA, Egger M. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.  J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):e8-16. PMC3894575
 28) Samji H, Cescon A, Hogg RS, Modur S, Althoff KN, Buchacz K, Burchell AN, Cohen M, Gebo KA, Gill MJ, Justice AC, Kirk G, Klein MB, Korthuis PT, Martin J, Napravnik S, Rourke SB, Sterling TR, Silverberg MJ, Deeks S, Jacobson LP, Bosch RJ, Kitahata MM, Goedert JJ, Moore RD, Gange SJ for The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada.  PLoS One. 2013 Dec 18;8(12):e81355. PMC3867319
 29) Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Collier A, Samji H, Thorne JE, Althoff KN, Martin JN, Rodriguez B, Stuart EA, Gange SJ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA). Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009.  PLoS One. 2013 Nov 18;8(11):e78952. PMC3657490
 30) Lucas GM, Jing Y, Sulkowski M, Abraham AG, Estrella MM, Atta MG, Fine DM, Klein MB, Silverberg MJ, Gill MJ, Moore RD, Gebo KA, Sterling TR, Butt AA; NA-ACCORD of the IeDEA. Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.  J Infect Dis. 2013 Oct 15;208(8):1240-9. Epub 2013 Jul 31. PMC3778973
 31) Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, Lau B, Althoff KN, Crane HM, Collier AC, Samji H, Thorne JE, Gill MJ, Klein MB, Martin JN, Rodriguez B, Rourke SB, Gange SJ; for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS. Trends and Disparities in Antiretroviral Therapy Initiation and Virologic Suppression Among Newly Treatment-Eligible HIV-Infected Individuals in North America, 2001-2009.  Clin Infect Dis. 2013 Apr;56(8):1174-82. PMC3657490
 32) Abraham AG, Strickler HD, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, Saag MS, Rourke SB, Rachlis A, Napravnik S, Moore RD, Klein MB, Kitahata MM, Kirk G, Hogg RS, Hessol NA, Goedert JJ, Gill MJ, Gebo KA, Eron JJ, Engels EA, Dubrow R, Crane HM, Brooks JT, Bosch RJ, D'Souza G; for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Invasive cervical cancer risk among HIV-infected women: A North American multi-cohort collaboration prospective study.  J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):405-13. PMC3633634
 33) Rebeiro PF, Althoff KN, Buchacz K, Gill MJ, Horberg MA, Krentz H, Brooks JT, Gebo KA, Sterling TR, Moore RD, Mugavero MJ, Martin JN, Klein MB, Hogg RS, Silverberg MJ, Rourke SB, Thorne J and Gange SJ; for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Retention Among North American HIV-infected Persons in Clinical Care, 2000-2008.<  J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):356-62. PMC3661708
 34) Justice AC, Modur S, Tate J, Althoff KN, Jacobson LP, Gebo KA, Kitahata MM, Horberg MA, Brooks JT, Buchacz K, Rourke SB, Rachlis A, Napravnik S, Eron JJ, Willig JH, Moore RD, Kirk GD, Bosch RJ, Rodriguez B, Hogg RS, Thorne JE, Goedert JJ, Klein MB, Gill MJ, Deeks SG, Sterling TR, Anastos K, Gange SJ; for the NA-ACCORD and VACS Project Teams. Predictive Accuracy of the Veterans Aging Cohort Study (VACS) Index for Mortality with HIV Infection: A North American Cross Cohort Analysis.  J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):149-63. PMC3619393
35) Althoff KN, Buchacz K, Hall HI, Zhang J, Hanna DB, Rebeiro PF, Gange SJ, Moore RD, Kitahata MM, Gebo KA, Martin J, Justice AC, Horberg MA, Hogg RS, Sterling TR, Cescon A, Klein MB, Thorne JE, Crane HM, Mugavero MJ, Napravnik S, Kirk GD, Jacobson LP, Brooks JT; North American AIDS Cohort Collaboration on Research and Design. U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.  Ann Intern Med. 2012 Sep 4;157(5):325-35. PMC3534765
36) Silverberg MJ, Lau B, Justice AC, Engels EA, Gill MJ, Goedert JJ, Kirk GD, D’Souza G, Bosch RJ, Brooks JT, Napravnik S, Hessol NA, Jacobson LP, Kitahata MM, Klein MB, Moore RD, Rodriguez B, Rourke SB, Saag MS, Sterling TR, Gebo KA, Press N, Martin JN, Dubrow R, for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Risk of Anal Cancer in HIV-Infected and HIV-uninfected Individuals in North America.  Clin Infect Dis 2012 54(7):1026-34. PMC3297645
37) Sterling TR, Lau B, Zhang J, Freeman AM, Bosch RJ, Brooks JT, Deeks SG, French A, Gange SJ, Gebo KA, Gill MJ, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Klein MB, Martin JN, Rodriguez, B, Silverberg MJ, Willig JH, Eron JJ, Goedert JJ, Hogg RS, Justice AC, McKaig RG, Napravnik S, Thorne J, Moore RD, for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Risk Factors for Tuberculosis After Highly Active Antiretroviral Therapy Initiation in the United States and Canada: Implications for Tuberculosis Screening.  J Infect Dis. 2011 204: 893-901. PMC3156918
38) Abraham AG, Lau B, Deeks S, Moore RD, Zhang J, Eron JJ, Harrigan R, Gill MJ, Kitahata MM, Klein MB, Napravnik S, Rachlis A, Rodriguez B, Rourke SB, Benson C, Bosch RJ, Collier A, Gebo KA, Goedert JJ, Hogg RS, Horberg MA, Jacobson LP, Justice AC, Kirk GD, Martin JN, McKaig RG, Silverberg MJ, Sterling TR, Thorne JE, Willig JH, Gange SJ. Missing Data on the Estimation of the Prevalence of Accumulated Human Immunodeficiency Virus Drug Resistance in Patients Treated With Antiretroviral Drugs in North America.  Am J Epidemiol. 2011 Sep 15;174(6):727-35. PMC21813792
39) Lau B, Cole SR, Gange SJ. Parametric mixture models to evaluate and summarize hazard ratios in the presence of competing risks with time-dependent hazards and delayed entry.  Stat Med. 2011 Mar 15;30(6):654-65. doi: 10.1002/sim.4123. PMC21337360
40) Althoff KN, Gebo KA, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Eron JJ, Napravnik S, Rourke SB, Gill MJ, Rodriguez B, Sterling TR, Deeks SG, Martin JN, Jacobson LP, Kirk GD, Collier AC, Benson CA, Silverberg MJ, Goedert JJ, McKaig RG, Thorne J, Rachlis A, Moore RD, Justice AC; for the North American AIDS Cohort Collaboration on Research and Design. CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation?  AIDS Res Ther. 2010 Dec 15;7(1):45. PMC3022663
41) Althoff KN, Justice AC, Gange SJ, Deeks SG, Saag MS, Silverberg MJ, Gill MJ, Lau B, Napravnik S, Tedaldi E, Klein MB, Gebo KA; for the North American AIDS Cohorts Collaboration on Research, Design (NA-ACCORD). Virologic and immunologic response to HAART, by age and regimen class.  AIDS. 2010 Oct 23;24(16):2469-79. PMC20829678
42) Kitahata MM. When to start antiretroviral therapy.  Top HIV Med. 2010 Aug-Sep;18(3):121-6. PMC20921578
43) Lau B, Chander G, Gange SJ, Moore RD. Identifying individuals with virologic failure after initiating effective antiretroviral therapy: The surprising value of mean corpuscular hemoglobin in a cross-sectional study.  AIDS Res Ther. 2010 Jul 23;7:25. PMC2922076
44) Althoff KN, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Justice AC, Gebo KA, Eron JJ, Rourke SB, Gill MJ, Rodriguez B, Sterling TR, Deeks SG, Martin JN, Rachlis AR, Napravnik S, Jacobson LP, Kirk GD, Collier AC, Benson CA, Silverberg MJ, Goedert JJ, McKaig RG, Van Rompaey SE, Zhang J. Moore RD. Late Presentation for HIV Care in the United States and Canada. Clin Infect Dis. 2010 Jun 1;50(11):1512-20. PMC2862849
45) Deeks SG, Gange SJ, Kitahata MM, Saag MS, Justice AC, Hogg RS, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Benson CA, Collier AC, Martin JN, Klein MB Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Kushel MB, Goedert JJ, McKaig RG, Moore RD for the North American AIDS Cohort Collaboration on Research and Design.   Trends in Multi-Drug Failure and Subsequent Mortality among Antiretroviral Therapy-Experienced HIV-Infected Patients in North America.  Clin Infect Dis. 2009 Nov: 49 (10): 1582–1590. PMC2871149
46) Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD, for the NA-ACCORD. Effect of early versus delayed antiretroviral therapy for HIV on survival.  N Engl J Med. 2009;360:1815-1826. [With Editorial Commentary]. PMC2854555
47) Lau B, Gange SJ, Kirk GD, and Moore RD.  Evaluation of human immunodeficiency virus biomarkers: inferences from interval and clinical cohort studies.  Epidemiology 2009 20(5):664-72. PMC2818534
48) Lau B, Cole SR, and Gange SJ. Competing risk regression models for epidemiologic data  Am J Epidemiol 2009 Jul 15;170(2):244-56. PMC2732996
49) Lau B, Cole SR, Moore RD, Gange SJ. Evaluating competing adverse and beneficial outcomes using a mixture model.  Statistics in Medicine 2008;27(21):4313-27. PMC2251745
50) Lau B, Gange SJ, Moore RD.  Interval and clinical cohort studies: epidemiological issues.  AIDS Res Hum Retroviruses. 2007 Jun;23(6):769-76. PMC 17604539
51) Gange SJ, Kitahata MM, Saag MS, Bangsberg DR, Bosch RJ, Brooks JT, Calzavara L, Deeks SG, Eron JJ, Gebo KA, Gill MJ, Haas DW, Hogg RS, Horberg MA, Jacobson LP, Justice AC, Kirk GD, Klein MB, Martin JN, McKaig RG, Rodriguez B, Rourke SB, Sterling TR, Freeman AM, Moore RD. Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).  Int J Epidemiol. 2007 Apr;36(2):294-301. PMC2820873

 

Files: 
AttachmentSize
NA-ACCORD_Dossier_20170202.pdf467.23 KB